SERUM HDL-CHOLESTEROL, APO-A-I AND APO-E LEVELS IN PATIENTS WITH ABNORMAL CORONARY-ARTERIES

被引：0
|
作者：
TAN, MH
WELDON, KL
ALBERS, JJ
CHEUNG, MC
HAVEL, RJ
VIGNE, JL
机构：
来源：
CLINICAL AND INVESTIGATIVE MEDICINE-MEDECINE CLINIQUE ET EXPERIMENTALE | 1980年 / 3卷 / 3-4期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：225 / 232
页数：8
相关论文
共 50 条
  • [41] Haplotype analysis of two APOA1/MspI polymorphisms in relation to plasma levels of apo A-I and HDL-cholesterol
    Kamboh, MI
    Aston, CE
    Nestlerode, CM
    McAllister, AE
    Hamman, RF
    ATHEROSCLEROSIS, 1996, 127 (02) : 255 - 262
  • [42] Evaluation of Apo B, Non-HDL Cholesterol Levels and Apo B/Apo A-1 Ratio in Patients with Type 2 Diabetes
    Altinova, Alev Eroglu
    Akturk, Mujde
    Toruner, Fusun
    Cakir, Nuri
    Arslan, Metin
    GAZI MEDICAL JOURNAL, 2013, 24 (03): : 78 - 80
  • [43] Apo A-I promoter polymorphism influences basal HDL-cholesterol and its response to pravastatin therapy
    Lahoz, C
    Peña, R
    Mostaza, JM
    Jiménez, J
    Subirats, E
    Pintó, X
    Taboada, M
    López-Pastor, A
    ATHEROSCLEROSIS, 2003, 168 (02) : 289 - 295
  • [44] Impact of Apo E polymorphism on Apo E serum levels in Alzheimer's disease patients and in centenarians
    Panza, F
    Solfrizzi, V
    Colacicco, AM
    Basile, AM
    Mastroianni, F
    Torres, F
    Scicutella, G
    Capurso, A
    ATHEROSCLEROSIS, 1999, 145 : S14 - S14
  • [45] VARIATION AT THE APOLIPOPROTEIN GENE LOCI CONTRIBUTES TO THE DETERMINATION OF PLASMA APO AI AND HDL-CHOLESTEROL LEVELS IN PATIENTS WITH CORONARY-ARTERY DISEASE AND HEALTHY CONTROLS
    HUMPHRIES, S
    KESSLING, A
    WILE, D
    JEENAH, M
    MILLER, N
    HIGH DENSITY LIPOPROTEINS AND ATHEROSCLEROSIS II, 1989, 826 : 87 - 94
  • [46] STUDY OF LIPIDS (CHOLESTEROL, TRIGLYCERIDES AND PHOSPHOLIPIDS), PLASMA-LIPOPROTEINS (HDL-CHOLESTEROL) AND APOPROTEINS (APO-A AND APO-B) IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION
    PANIAGUA, J
    MUNOZ, AM
    TUSET, N
    GRAS, J
    MEDICINA CLINICA, 1989, 93 (04): : 134 - 138
  • [47] REPLACEMENT OF MOUSE HDL BY PARTICLES SIMILAR TO HUMAN HDL SUBCLASSES IN TRANSGENIC MICE EXPRESSING HIGH-LEVELS OF HUMAN APO-A-I
    ISHIDA, BY
    CLIFT, SM
    KRAUSS, RM
    RUBIN, EM
    ARTERIOSCLEROSIS, 1990, 10 (05): : A773 - A773
  • [48] Relationship between serum iron and HDL-cholesterol levels in hyperlipidemic patients
    Jacob, N
    Bruckert, E
    Marchand, C
    Giral, P
    Foglietti, MJ
    Turpin, G
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 1998, 8 (02) : 77 - 83
  • [49] PROBUCOL REDUCES HDL-C LEVELS BY DECREASING APO-A-I TRANSPORT RATE IN A HUMAN A-I TRANSGENIC MOUSE MODEL
    HAYEK, T
    CHAJEK, T
    WALSH, A
    BRESLOW, JL
    ARTERIOSCLEROSIS, 1990, 10 (05): : A763 - A763
  • [50] Apo-E serum levels - Indicator for disease activity, differentiation of disease subtype, and therapy response in multiple sclerosis?
    Elitok, E
    Kitze, B
    Bitsch, A
    Bahner, D
    Bogumil, T
    Dressel, A
    Polak, T
    Weber, F
    Rieckmann, P
    Poser, S
    Tumani, H
    NEUROLOGY, 2000, 54 (07) : A349 - A349
12345